OA03.01 Unveiling the Anti-Tumor Activity of Exarafenib in BRAF-Mutated NSCLC Through Genomic Analysis and Combined Preclinical, Clinical Outcomes
2025 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2025.03.006
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
395
Citations
7
h-index
6
i10-index
Tim Sen Wang is an academic researcher from RG Biopharma (United States). The author has contributed to research in topics: Melanoma and MAPK Pathways & Computational Drug Discovery Methods & Synthesis and biological activity. The author has an h-index of 7, co-authored 16 publications.
ORCID: 0000-0001-5518-508XClick to start Chat